Feng Wen, Tianhai Lin, Ping Tan, Jiani Deng, Min Ren, Mengni Zhang, Xiaonan Zheng, Peng Zhang, Yali Shen. "A multi-center phase Ib/II study of RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with HER2 positive locally advanced muscle-invasive urothelial bladder cancer (Hope-03).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.795